Nephritis Nexus: Embarking on a 5.2% Growth Expedition in the Global Market (2022-2029)

The global nephritis market is anticipated to witness major growth during the forecast period. According to the CDC reports, more than 37 million people in the U.S. are expected to suffer from chronic kidney disease, whereas globally more than 500 million people are affected. Genetics may also play a role in developing nephritis, such as for chronic glomerulonephritis. For those who may be at higher risk, routine bloodwork and urine testing can be done to look at levels of a compound called creatinine that will reflect kidney function.
Data Bridge Market Research analyses a growth rate in the global nephritis market in the forecast period 2022-2029. The expected CAGR of global nephritis market is tend to be around 5.2% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Nephritis Market Dynamics
Drivers
• Increased Incidence of Kidney Diseases
The increasing prevalence of chronic kidney disease worldwide is majorly responsible for boosting the growth of the global nephritis market. The National Kidney Foundation reports that around 10% of the global population is affected by chronic kidney disease (CKD). As per WHO facts 2019, around 1.13 billion people worldwide have hypertension. In the year 2014-2016, diabetes and hypertension were responsible for approximately 75% of kidney failure. Thus, it boosts the market growth.

COVID-19 Impact on Global Nephritis Market
The growing cases of COVID-19 directly correlate with the growth of kidney-related diseases. Patients with glomerular disease on immunosuppressive drugs may be more prone to infections. In some patients with glomerular illness, the specialists change their immunosuppressive drugs based on their risk of developing end-stage kidney disease and the local transmission of COVID-19. Furthermore, glomerular lesions were witnessed in a minority of patients with COVID-19, that collapse focal segmental glomerulosclerosis (FSGS), also called COVID-associated nephropathy (COVAN).

Therefore, it has been found that the COVID-19 virus is having a major impact on the kidney of patients, which in turn, is projected to upsurge the burden of kidney disorders in the near future and boost the market growth. Thus, overall, COVID-19 had a major impact on the global nephritis market.

Get More Info : https://www.databridgemarketresearch.com/reports/global-nephritis-market

Key players operating in the global nephritis market include:
• Pfizer Inc (U.S.)
• AstraZeneca (U.K.)
• Bristol-Myers Squibb Company (U.S.)
• Abbvie,Inc (U.S.)
• Dr. Reddy's Laboratories Ltd (India)
• Endo International plc (Ireland)
• Teva Pharmaceutical Industries Ltd (Israel)
• Sun Pharmaceutical Industries Ltd (India)
• Mylan N.V. (U.S.)
• Novartis AG (Switzerland)
• Lupin (India)
• Cipla Inc (India)

More Links:
https://dbmr232343.blogspot.com/2023/07/middle-east-and-africa-endoscopic.html

https://dbmr232343.blogspot.com/2023/07/north-america-endoscopic-retrograde.html

https://dbmr232343.blogspot.com/2023/07/hunter-syndrome-treatment-market.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.